文献速递妇科

卵巢癌肿瘤细胞减灭术后主要术后并发症对复发和长期生存的影响

The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2022-05-12

这项回顾性多中心研究纳入2008年1月至2015年12月间549例IIIC-IV期卵巢癌患者,均接受肿瘤细胞减灭术且残留病灶微小或无。主要术后并发症(≥3级)总体发生率为22.4%,初次肿瘤细胞减灭术组为28.6%,早期间歇性肿瘤细胞减灭术组为23.2%,延迟肿瘤细胞减灭术组为14.0%。多因素分析显示主要并发症与无病生存期显著相关,但与总生存期无关。

要点

  • 主要术后并发症(≥3级)总体发生率为22.4%,初次肿瘤细胞减灭术组最高(28.6%)。
  • 广泛腹膜切除和手术时机是主要并发症的预测因素。
  • 主要并发症与无病生存期显著相关,但与总生存期无关。

核心结论

  • 发生主要术后并发症的患者与无主要并发症患者相比无病生存期缩短。
  • 广泛腹膜切除和手术时机是术后并发症的预测因素。

研究设计与样本

  • 回顾性多中心研究,纳入2008年1月至2015年12月间549例IIIC-IV期(FIGO分期)卵巢癌患者。
  • 患者接受初次肿瘤细胞减灭术(PDS)、3-4周期新辅助化疗后早期间歇性肿瘤细胞减灭术(IDS)或6周期后延迟肿瘤细胞减灭术(DDS),且残留病灶微小或无。
  • 采用单因素和多因素分析识别与主要手术并发症(≥3级)相关的因素,并按主要术后并发症的发生评估无病生存期(DFS)和总生存期(OS)。

主要发现

  • 主要手术并发症总体发生率为22.4%。
  • PDS组主要并发症发生率为28.6%,早期IDS组为23.2%,DDS组为14.0%。
  • 多因素分析显示广泛腹膜切除和手术时机与主要并发症的发生相关。
  • 主要并发症组中位DFS为16.9个月(95%CI=[13.7-18.4]),无主要并发症组为20.1个月(95%CI=[18.6-22.4])。
  • 主要并发症组中位OS为48.0个月(95%CI=[37.2-73.1]),无主要并发症组为56.7个月(95%CI=[51.2-70.4])。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the impact on survival of major postoperative complications and to identify the factors associated with these complications in patients with advanced ovarian cancer after cytoreductive surgery. METHODS: We designed a retrospective multicenter study collecting data from patients with IIIC-IV FIGO Stage ovarian cancer who had undergone either primary debulking surgery (PDS), early interval debulking surgery (IDS) after 3-4 cycles of neoadjuvant chemotherapy, or delayed debulking surgery (DDS) after 6 cycles, with minimal or no residual disease, from January 2008 to December 2015. Univariable and multivariable analyses were conducted to identify factors associated with major surgical complications (≥Grade 3). We assessed disease-free survival (DFS) and overall survival (OS) rates according to the occurrence of major postoperative complications. RESULTS: 549 women were included. The overall rate of major surgical complications was 22.4%. Patients who underwent PDS had a higher rate of major complications (28.6%) than patients who underwent either early IDS (23.2%) or DDS (14.0%). Multivariable analysis revealed that extensive peritonectomy and surgical timing were associated with the occurrence of major complications. Median DFS and OS were 16.9 months (95%CI = [13.7-18.4]) and 48.0 months (95%CI = [37.2-73.1]) for the group of patients with major complications, and 20.1 months (95%CI = [18.6-22.4]) and 56.7 months (95%CI = [51.2-70.4]) for the group without major complications. Multivariable analysis revealed that major surgical complications were significantly associated with DFS, but not with OS. CONCLUSIONS: Patients who experienced major surgical complications had reduced DFS, compared with patients without major morbidity. Extensive peritonectomy and surgical timing were predictive factors of postoperative morbidity.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Angeles MA, Hernández A, Pérez-Benavente A, et al. The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2022. PMID: 35568582. doi:10.1016/j.ygyno.2022.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。